FROM PAGE B1

The move cleared the company’s reporting backlog, allowing the LSE to lift the suspension and resume trading in the GDRs from June 26.

The DBA thanked Finance and Planning Minister Amir Khosru Mahmud Chowdhury, Prime Minister’s Special Assistant for Investment and Capital Markets Tanvir Hani, BSEC Chairman Masud Khan, BSEC commissioners and officials, and the board and management of Beximco Pharma for their roles in resolving the issue.

Meanwhile, Beximco Pharma reported a net profit of Tk 699 crore for FY25, its highest annual earnings since listing on the stock market, driven by strong sales growth. Following the record performance, the board declared a 47.5 percent cash dividend for FY25, the largest cash payout in the company’s history.